Semaglutide
This prescription GLP-1 medicine acts on pathways involved in appetite, fullness and digestion. A prescriber decides whether it is appropriate.
PRESCRIBER-MANAGED PROGRAMS
Semaglutide and tirzepatide are prescription medicines that belong inside ongoing clinical care. The website explains the programs; a licensed prescriber determines eligibility, medication and dose.
WHAT TO KNOW
Responsible care includes clinical screening, a prescription when appropriate, education, monitoring and follow-up.
This prescription GLP-1 medicine acts on pathways involved in appetite, fullness and digestion. A prescriber decides whether it is appropriate.
This prescription medicine acts on GIP and GLP-1 pathways. It is not simply “stronger semaglutide,” and medication choice is individualized.
Clinical intake occurs in a secure healthcare process. Health history, current medicines, pregnancy plans and relevant risks are reviewed before prescribing.
Before payment, confirm the exact prescribed product, dispensing source and whether it is FDA-approved or compounded. Compounded drugs are not FDA-approved products.
LOCAL SERVICE AREA
Program availability is considered for Rancho Cucamonga, Claremont, Fontana, Rialto and surrounding communities.
REVIEW THE PROGRAM
Eligibility, medication, dose and ongoing monitoring are determined through licensed care.